Compare CHE & AFRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CHE | AFRM |
|---|---|---|
| Founded | 1970 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6B | 14.3B |
| IPO Year | 1994 | 2020 |
| Metric | CHE | AFRM |
|---|---|---|
| Price | $434.22 | $66.31 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 25 |
| Target Price | ★ $501.50 | $84.52 |
| AVG Volume (30 Days) | 245.6K | ★ 5.0M |
| Earning Date | 04-23-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.57% | N/A |
| EPS Growth | N/A | ★ 108.98 |
| EPS | ★ 4.84 | 0.90 |
| Revenue | $2,529,978,000.00 | ★ $3,224,412,000.00 |
| Revenue This Year | $6.56 | $30.78 |
| Revenue Next Year | $6.23 | $23.95 |
| P/E Ratio | $88.01 | ★ $74.74 |
| Revenue Growth | 4.06 | ★ 38.80 |
| 52 Week Low | $365.21 | $42.10 |
| 52 Week High | $583.96 | $100.00 |
| Indicator | CHE | AFRM |
|---|---|---|
| Relative Strength Index (RSI) | 68.15 | 57.94 |
| Support Level | $423.89 | $66.21 |
| Resistance Level | $457.32 | $70.72 |
| Average True Range (ATR) | 11.13 | 3.65 |
| MACD | 0.77 | -0.50 |
| Stochastic Oscillator | 98.02 | 56.93 |
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. The company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.
Founded in 2012, Affirm is a market leader in the buy-now, pay-later space with around $36 billion in transaction volume in fiscal 2025. Affirm offers both zero-interest financing, which is merchant subsidized, and interest-bearing loans, which function as personal loans that are approved on a per-transaction basis. Over 70% of Affirm's transaction volume comes from its interest-bearing loans, which also comprise the majority of its revenue. Affirm operates in the United States, which accounted for more than 95% of its revenue in 2025, but the firm has also expanded to Canada and the United Kingdom.